SUPV3L1

Suv3 like RNA helicase, the group of RNA helicases

Basic information

Region (hg38): 10:69180234-69209099

Links

ENSG00000156502NCBI:6832OMIM:605122HGNC:11471Uniprot:Q8IYB8AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SUPV3L1 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SUPV3L1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
2
missense
40
clinvar
1
clinvar
41
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 40 3 0

Variants in SUPV3L1

This is a list of pathogenic ClinVar variants found in the SUPV3L1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
10-69180304-C-G not specified Uncertain significance (Feb 22, 2023)2487275
10-69180307-G-T not specified Uncertain significance (Feb 13, 2024)3172198
10-69180377-G-A not specified Uncertain significance (Oct 16, 2023)3172211
10-69180390-G-A Likely benign (Apr 01, 2022)2640543
10-69180418-T-G not specified Uncertain significance (May 06, 2022)2287762
10-69180452-G-C not specified Uncertain significance (Dec 17, 2023)3172196
10-69180461-A-G not specified Uncertain significance (Nov 30, 2022)2288643
10-69180488-C-T not specified Uncertain significance (Aug 17, 2021)2365654
10-69180508-G-A not specified Uncertain significance (Aug 01, 2022)2382327
10-69186479-A-C not specified Uncertain significance (Oct 04, 2022)2316785
10-69186536-T-C not specified Uncertain significance (Dec 12, 2023)3172209
10-69186544-G-A not specified Likely benign (Jan 23, 2024)3172210
10-69187665-T-A not specified Uncertain significance (Feb 14, 2023)2468551
10-69187689-A-G not specified Uncertain significance (Dec 06, 2022)2398805
10-69187722-C-T not specified Uncertain significance (Sep 14, 2021)2351591
10-69189356-A-T not specified Uncertain significance (Apr 20, 2024)3323657
10-69189365-C-A not specified Uncertain significance (Jun 17, 2022)2391113
10-69189427-A-G not specified Uncertain significance (Feb 11, 2022)2277178
10-69191758-C-G not specified Uncertain significance (Aug 02, 2021)2241060
10-69197036-A-G not specified Uncertain significance (Jan 30, 2024)3172212
10-69197066-A-G not specified Uncertain significance (Dec 13, 2022)2367072
10-69198382-A-G not specified Uncertain significance (Oct 26, 2022)2407391
10-69198442-G-A not specified Uncertain significance (Apr 18, 2023)2524517
10-69198495-C-T not specified Uncertain significance (Jul 14, 2021)2237249
10-69199143-A-G not specified Uncertain significance (Apr 04, 2023)2544697

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SUPV3L1protein_codingprotein_codingENST00000359655 1528868
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.03200.9681257250221257470.0000875
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.153644310.8450.00002155157
Missense in Polyphen78139.240.560171729
Synonymous-0.3491611551.040.000007721533
Loss of Function4.071036.50.2740.00000203435

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001160.000116
Ashkenazi Jewish0.000.00
East Asian0.0001650.000163
Finnish0.00004620.0000462
European (Non-Finnish)0.00006210.0000615
Middle Eastern0.0001650.000163
South Asian0.0002350.000229
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Major helicase player in mitochondrial RNA metabolism. Component of the mitochondrial degradosome (mtEXO) complex, that degrades 3' overhang double-stranded RNA with a 3'-to-5' directionality in an ATP-dependent manner. ATPase and ATP- dependent multisubstrate helicase, able to unwind double-stranded (ds) DNA and RNA, and RNA/DNA heteroduplexes in the 5'-to-3' direction. Plays a role in the RNA surveillance system in mitochondria; regulates the stability of mature mRNAs, the removal of aberrantly formed mRNAs and the rapid degradation of non coding processing intermediates. Also implicated in recombination and chromatin maintenance pathways. May protect cells from apoptosis. Associates with mitochondrial DNA. {ECO:0000269|PubMed:12466530, ECO:0000269|PubMed:15096047, ECO:0000269|PubMed:17352692, ECO:0000269|PubMed:17961633, ECO:0000269|PubMed:18678873, ECO:0000269|PubMed:19509288, ECO:0000269|PubMed:19864255}.;

Recessive Scores

pRec
0.122

Intolerance Scores

loftool
0.552
rvis_EVS
-0.98
rvis_percentile_EVS
8.85

Haploinsufficiency Scores

pHI
0.266
hipred
Y
hipred_score
0.618
ghis
0.576

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
E
essential_gene_gene_trap
E
gene_indispensability_pred
E
gene_indispensability_score
0.943

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Supv3l1
Phenotype
skeleton phenotype; immune system phenotype; hearing/vestibular/ear phenotype; digestive/alimentary phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; embryo phenotype; cellular phenotype; craniofacial phenotype; muscle phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype;

Zebrafish Information Network

Gene name
supv3l1
Affected structure
hepatocyte
Phenotype tag
abnormal
Phenotype quality
disorganized

Gene ontology

Biological process
mitochondrial mRNA catabolic process;positive regulation of mitochondrial RNA catabolic process;mitochondrial RNA 3'-end processing;DNA recombination;RNA catabolic process;positive regulation of cell growth;DNA duplex unwinding;mitochondrial ncRNA surveillance;mitochondrial mRNA surveillance;negative regulation of apoptotic process;mitochondrion morphogenesis;chromatin maintenance;mitochondrial RNA surveillance
Cellular component
nucleus;mitochondrion;mitochondrial matrix;mitochondrial nucleoid;mitochondrial degradosome
Molecular function
DNA binding;DNA helicase activity;RNA binding;double-stranded RNA binding;ATP-dependent RNA helicase activity;helicase activity;protein binding;ATP binding;3'-5' RNA helicase activity;protein homodimerization activity